ULTRA LONG PULSE SELECTIVE PHOTOTHERMOLYSIS

Information

  • Research Project
  • 2224461
  • ApplicationId
    2224461
  • Core Project Number
    R44HL048388
  • Full Project Number
    2R44HL048388-02A1
  • Serial Number
    48388
  • FOA Number
  • Sub Project Id
  • Project Start Date
    8/1/1992 - 31 years ago
  • Project End Date
    7/31/1997 - 26 years ago
  • Program Officer Name
  • Budget Start Date
    8/1/1995 - 28 years ago
  • Budget End Date
    7/31/1996 - 27 years ago
  • Fiscal Year
    1995
  • Support Year
    2
  • Suffix
    A1
  • Award Notice Date
    7/29/1995 - 28 years ago
Organizations

ULTRA LONG PULSE SELECTIVE PHOTOTHERMOLYSIS

DESCRIPTION: (Adapted from investigator's abstract) The effectiveness of Selective Photothermolysis (SD) is well established. SP theory, when applied to the treatment of vascular lesions, in particular Port Wine Stain birthmarks, calls for a laser emitting 5 J/cm2 at 577 nm, with pulse duration of 3 msec. But, lasers meeting the important pulse duration requirement are unavailable. Flashlamp excited dye lasers produce pulses at most 0.5 msec long, and CW type lasers with robotic attachment produce pulses 30 msec in duration or longer. Data does not exist in the important 1 to 10 msec regime. Clinical end points for the overly short pulses are unsatisfactory, leading to purpura and repeated treatments, while, with the overly long pulses, selectivity is lost resulting in epidermal damage. Phase I determined that a single FEDL cannot produce the requisite pulse duration, but a solution for the problem was recommended. Subsequent to the Phase I studies, a laser built according to the recommendation was used in tests on animals. These tests show that optimum pulse durations are decidedly better. An ultra long pulse dye laser for commercial use will be built in Phase II and tested clinically. New protocols at reduced fluences will eliminate acute purpura and reduce the number of treatments necessary for clearing. This will allow the treatment of leg veins, a heretofore intractable problem. PROPOSED COMMERCIAL APPLICATION: There is a large market for dermatology treatments off the type described in this project. New laser technology that would make the laser treatment better, more widely applicable, more efficient, and less expensive would have a significant on the commercial aspects of this field.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R44
  • Administering IC
    HL
  • Application Type
    2
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG7
  • Study Section Name
  • Organization Name
    CYNOSURE, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    CHELMSFORD
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    01824
  • Organization District
    UNITED STATES